CLINICAL_TRIALS
trial_result
· 2025-11-19
Clinical Trial Update: The Advisor Pro Direct Study [NA]
Summary
The Advisor Pro Direct Study (NCT03774069), sponsored by Rabin Medical Center for Type 1 Diabetes Mellitus, has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Rabin Medical Center | Conditions: Type 1 Diabetes Mellitus | NA | Status: TERMINATED